Atorvastatin Calcium Trihydrate 20 mg Tablets
Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Hwanin Pharmaceutical Co., Ltd.
MFDS item code 201701568 · Approved 2017.03.31 · Insurance code 657203260
Improvement of hyperlipidemia (including familial hyperlipidemia in children); prevention of cardiovascular disease
This medication is used to reduce the risk of cardiovascular diseases. It specifically lowers the risk of myocardial infarction and stroke in adults with risk factors for coronary heart disease and in patients with type 2 diabetes. Additionally, it is effective in reducing the risk of non-fatal myocardial infarction, stroke, vascular surgery, and hospitalization due to congestive heart failure in patients with heart disease. In patients with hyperlipidemia, it helps lower cholesterol, LDL cholesterol, and triglyceride levels while increasing HDL cholesterol. This medication is also used in various types of dyslipidemia that do not respond adequately to diet. It is safe for use in pediatric patients with heterozygous familial hypercholesterolemia and contributes to reducing cardiovascular risk factors. Therefore, it is used for the prevention and improvement of cardiovascular diseases and hyperlipidemia.
Patients receiving atorvastatin, both before and during treatment, should follow a standard cholesterol-lowering diet. This drug may be taken at any time of day, without regard to food. Hyperlipidemia: The recommended initial dose is atorvastatin 10 mg once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when starting treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia: The dose of this drug is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. Patients with renal impairment: No dose adjustment is necessary because renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect. Older adults: Efficacy and safety in patients aged 70 years or older are generally similar to those in the usual adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this drug greater than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.
This medication may cause unusual symptoms in muscles; if muscle pain or weakness worsens, consult a doctor immediately. This medication should not be used in patients with severe liver disease or in pregnant or nursing women, or children under 10 years of age. Since it may affect liver function, regular liver function tests are necessary, and any unusual liver symptoms should be reported immediately. It is advisable to avoid or reduce alcohol consumption while taking this medication. If taken with certain medications, drug concentrations may increase, raising the risk of side effects, so inform your doctor or pharmacist about other medications being taken. Women of childbearing potential should use appropriate contraceptive methods while taking this medication and discontinue use if pregnancy is confirmed. If muscle-related abnormal symptoms or significantly elevated muscle enzyme levels occur, discontinue the medication and consult healthcare professionals. This medication can cause severe skin reactions; if a rash or blisters develop, discontinue use immediately and seek medical attention. Elderly patients or those with impaired kidney function may have a higher risk of side effects while taking this medication and should be observed closely. This medication should be stored out of the reach of children and in a designated container to prevent misuse or deterioration of quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1°C and 30°C. Proper storage will help preserve the medication's efficacy and safety for an extended period.
White round film-coated tablet
100 tablets/bottle, 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Hwanin Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.